Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 78380, 6 pages
http://dx.doi.org/10.1155/MI/2006/78380
Research Communication

The Levels of Ghrelin, Leptin, TNF-α, and IL-6 in Liver Cirrhosis and Hepatocellular Carcinoma due to HBV and HDV Infection

1Department of Gastroenterology, School of Medicine, Firat University, Elazığ 23200, Turkey
2Department of Internal Medicine, School of Medicine, Firat University, 23200 Elazığ, Turkey
3Department of Microbiology, School of Medicine, Firat University, 23200 Elazığ, Turkey
4Department of Biochemistry, School of Medicine, Firat University, Elazığ 23200, Turkey

Received 11 March 2006; Revised 29 March 2006; Accepted 30 March 2006

Copyright © 2006 Huseyin Ataseven et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G Montalto, M Cervello, L Giannitrapani, F Dantona, A Terranova, and L A Castagnetta, “Epidemiology, risk factors, and natural history of hepatocellular carcinoma,” Annals of the New York Academy of Sciences, vol. 963, pp. 13–20, 2002. View at Google Scholar · View at PubMed
  2. D M Parkin, F Bray, J Ferlay, and P Pisani, “Estimating the world cancer burden: Globocan 2000,” International Journal of Cancer, vol. 94, no. 2, pp. 153–156, 2001. View at Publisher · View at Google Scholar · View at PubMed
  3. F W Guglielmi, C Panella, A Buda et al., “Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the “Nutritional Problems in Gastroenterology” Section of the Italian Society of Gastroenterology (SIGE),” Digestive and Liver Disease, vol. 37, no. 9, pp. 681–688, 2005. View at Publisher · View at Google Scholar · View at PubMed
  4. T. Schütz, A-E. Roske, A-C. Lehmann, H. Lochs, and M. Plauth, “Pathogenesis of malnutrition in patients with hepatocellular carcinoma (HCC),” Clinical Nutrition, vol. 17, no. suppl 1, pp. 12–13, 1998. View at Google Scholar
  5. M Merli, O Riggio, and L Dally, “Does malnutrition affect survival in cirrhosis? (Policentrica Italiana Nutrizione Cirrosi),” Hepatology, vol. 23, no. 5, pp. 1041–1046, 1996. View at Publisher · View at Google Scholar · View at PubMed
  6. O Riggio, S Angeloni, L Ciuffa et al., “Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis,” Clinical Nutrition, vol. 22, no. 6, pp. 553–559, 2003. View at Publisher · View at Google Scholar
  7. “Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. Nutritional status in cirrhosis,” Journal of Hepatology, vol. 21, no. 3, pp. 317–325, 1994. View at Publisher · View at Google Scholar
  8. C L Rock, A M Coulstan, and M T Ruffin, “Diet therapy,” in Harrison's Principles of Internal Medicine, A S Fauci, E Braunwald, and K J Isselbacher, Eds., pp. 465–472, McGraw-Hil, New York, NY, 14th edition, 1998. View at Google Scholar
  9. M Kojima, H Hosoda, Y Date, M Nakazato, H Matsuo, and K Kangawa, “Ghrelin is a growth- hormone-releasing acylated peptide from stomach,” Nature, vol. 402, no. 6762, pp. 656–660, 1999. View at Publisher · View at Google Scholar
  10. M Nakazato, N Murakami, Y Date et al., “A role for ghrelin in the central regulation of feeding,” Nature, vol. 409, no. 6817, pp. 194–198, 2001. View at Publisher · View at Google Scholar
  11. M Shintani, Y Ogawa, K Ebihara et al., “Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway,” Diabetes, vol. 50, no. 2, pp. 227–232, 2001. View at Google Scholar · View at PubMed
  12. M Tschop, D L Smiley, and M L Heiman, “Ghrelin induces adiposity in rodents,” Nature, vol. 407, no. 6806, pp. 908–913, 2000. View at Publisher · View at Google Scholar
  13. A M Wren, C J Small, H L Ward et al., “The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion,” Endocrinology, vol. 141, no. 11, pp. 4325–4328, 2000. View at Publisher · View at Google Scholar
  14. J M Friedman and J L Halas, “Leptin and the regulation of body weight in mammals,” Nature, vol. 395, no. 6704, pp. 763–770, 1998. View at Publisher · View at Google Scholar
  15. J F Caro, M K Sinha, J W Kolaczynski, P L Zhang, and R V Considine, “Leptin: the tale of an obesity gene,” Diabetes, vol. 45, no. 11, pp. 1455–1462, 1996. View at Google Scholar
  16. J M Friedman, “Leptin, leptin receptors and the control of body weight,” European Journal of Medical Research, vol. 2, no. 1, pp. 7–13, 1997. View at Google Scholar · View at PubMed
  17. A Kennedy, T W Gettys, P Watson et al., “The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 4, pp. 1293–1300, 1997. View at Publisher · View at Google Scholar
  18. S G Bouret, S J Draper, and R B Simerly, “Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice,” Journal of Neuroscience, vol. 24, no. 11, pp. 2797–2805, 2004. View at Publisher · View at Google Scholar · View at PubMed
  19. R S Ahima and S Y Osei, “Leptin signaling,” Physiology & Behavior, vol. 81, no. 2, pp. 223–241, 2004. View at Google Scholar · View at PubMed
  20. R Faggioni, K R Feingold, and C Grunfeld, “Leptin regulation of the immune response and the immunodeficiency of malnutrition,” FASEB Journal, vol. 15, no. 14, pp. 2565–2571, 2001. View at Publisher · View at Google Scholar
  21. S Aleffi, I Petrai, C Bertolani et al., “Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells,” Hepatology, vol. 42, no. 6, pp. 1339–1348, 2005. View at Publisher · View at Google Scholar
  22. J Dötsch, K Nüsken, M Schroth, W Rascher, and U Meißner, “Alterations of leptin and ghrelin serum concentrations in renal disease: simple epiphenomena?,” Pediatric Nephrology, vol. 20, no. 6, pp. 701–706, 2005. View at Google Scholar
  23. B Beutler and A Cerami, “Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response,” Endocrine Reviews, vol. 9, no. 1, pp. 57–66, 1988. View at Google Scholar
  24. K J Tracey and A Cerami, “Tumor necrosis factor: a pleiotropic cytokine and therapeutic target,” Annual Review of Medicine, vol. 45, pp. 491–503, 1994. View at Publisher · View at Google Scholar
  25. S-S Wang, F-Y Lee, C-C Chan et al., “Sequential changes in plasma cytokine and endotoxin levels in cirrhotic patients with bacterial infection,” Clinical Science, vol. 98, no. 4, pp. 419–425, 2000. View at Publisher · View at Google Scholar
  26. M Odeh, E Sabo, I Srugo et al., “Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure,” Liver International, vol. 24, no. 2, pp. 110–116, 2004. View at Publisher · View at Google Scholar · View at PubMed
  27. J Le and J Vilcek, “Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response,” Laboratory Investigation, vol. 61, no. 6, pp. 588–602, 1989. View at Google Scholar
  28. J Deviere, J Content, C Denys et al., “High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production,” Clinical and Experimental Immunology, vol. 77, no. 2, pp. 221–225, 1989. View at Google Scholar
  29. C Gerstner, T Schuetz, V Von Baehr et al., “Correlation between energy expenditure, nutrient intake, malnutrition and activation of the inflammatory system in patients with hepatic cirrhosis,” Journal of Hepatology, vol. 34, no. suppl 1, pp. 195–196, 2001. View at Publisher · View at Google Scholar
  30. K Onodera, A Kato, and K Suzuki, “Serum leptin concentrations in liver cirrhosis: relationship to the severity of liver dysfunction and their characteristic diurnal profiles,” Hepatology Research, vol. 21, no. 3, pp. 205–212, 2001. View at Publisher · View at Google Scholar
  31. A Di Lelio, C Cestari, A Lomazzi, and L Beretta, “Cirrhosis: diagnosis with sonographic study of the liver surface,” Radiology, vol. 172, no. 2, pp. 389–392, 1989. View at Google Scholar
  32. M Bruix, J M Sherman, J M Llovet et al., “Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver,” Journal of Hepatology, vol. 35, no. 3, pp. 421–430, 2001. View at Publisher · View at Google Scholar
  33. M K Tü̈rkdoğan, H Bozkurt, I Uygan et al., “Chronic hepatitis delta virus infection in Van region of eastern Turkey,” The Turkish Journal of Gastroenterology, vol. 16, no. 1, pp. 17–20, 2005. View at Google Scholar
  34. P Groshiede and P Van Damme, “Epidemiology of hepatitis B infection, prevention and control of hepatitis B in the comunity,” in Communicable Disease Series. No: 1, J Hallauer, J Jane, E McCloy, A Merheus, and C Roure, Eds., pp. 17–26, World Health Organization, European Organization Office, Geneva, Switzerland, 1996. View at Google Scholar
  35. Ö Uzunalimoglu, C Yurdaydin, H Cetinkaya et al., “Risk factors for hepatocellular carcinoma in Turkey,” Digestive Diseases and Sciences, vol. 46, no. 5, pp. 1022–1028, 2001. View at Publisher · View at Google Scholar
  36. M Tajika, M Kato, H Mohri et al., “Prognostic value of energy metabolism in patients with viral liver cirrhosis,” Nutrition, vol. 18, no. 3, pp. 229–234, 2002. View at Publisher · View at Google Scholar
  37. F Tacke, G Brabant, E Kruck et al., “Ghrelin in chronic liver disease,” Journal of Hepatology, vol. 38, no. 4, pp. 447–454, 2003. View at Publisher · View at Google Scholar
  38. F F Casanueva and C Dieguez, “Ghrelin a new hormone implicated in the regulation of growth hormone secretion and body energy homeostasis,” Growth, Genetics & Hormones, vol. 20, no. 1, pp. 1–8, 2004. View at Google Scholar
  39. J Ockenga, S C Bischoff, H L Tillmann et al., “Elevated bound leptin correlates with energy expenditure in cirrhotics,” Gastroenterology, vol. 119, no. 6, pp. 1656–1662, 2000. View at Publisher · View at Google Scholar
  40. A J McCullough, E Bugianesi, G Marchesini, and S C Kalhan, “Gender-dependent alterations in serum leptin in alcoholic cirrhosis,” Gastroenterology, vol. 115, no. 4, pp. 947–953, 1998. View at Publisher · View at Google Scholar
  41. F F Bolukbas, C Bolukbas, M Horoz et al., “Child-Pugh classification dependent alterations in serum leptin levels among cirrhotic patients: a case controlled study,” BMC Gastroenterology, vol. 4, no. 1, p. 23, 2004. View at Publisher · View at Google Scholar
  42. R Testa, R Franceschini, E Giannini et al., “Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis,” Journal of Hepatology, vol. 33, no. 1, pp. 33–37, 2000. View at Publisher · View at Google Scholar
  43. S Y Lin, Y Y Wang, and W H Sheu, “Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis,” Clinical Endocrinology, vol. 57, no. 6, pp. 805–811, 2002. View at Publisher · View at Google Scholar
  44. A V Greco, G Mingrone, A Favuzzi et al., “Serum leptin levels in post-hepatitis liver cirrhosis,” Journal of Hepatology, vol. 33, no. 1, pp. 38–42, 2000. View at Publisher · View at Google Scholar
  45. A Comlekci, H Akpinar, S Yesil et al., “Serum leptin levels in patients with liver cirrhosis and chronic viral hepatitis,” Scandinavian Journal of Gastroenterology, vol. 38, no. 7, pp. 779–786, 2003. View at Publisher · View at Google Scholar
  46. D G Wahl, J-M Dollet, M Kreher, B Champigneulle, M-A Bigard, and P Gaucher, “Relationship of insulin resistance to protein-energy malnutrition in patients with alcoholic liver cirrhosis: effect of short-term nutritional support,” Alcoholism: Clinical and Experimental Research, vol. 16, no. 5, pp. 971–978, 1992. View at Publisher · View at Google Scholar
  47. S Y Kwon, S S Kim, O S Kwon et al., “Prognostic significance of glycaemic control in patients with HBV and HCV-related cirrhosis and diabetes mellitus,” Diabetic Medicine, vol. 22, no. 11, pp. 1530–1535, 2005. View at Publisher · View at Google Scholar
  48. E J Williams and J P Iredale, “Liver cirrhosis,” Postgraduate Medical Journal, vol. 74, no. 870, pp. 193–202, 1998. View at Google Scholar · View at PubMed
  49. H Tilg, A Wilmar, W Vogel et al., “Serum levels of cytokines in chronic liver diseases,” Gastroenterology, vol. 103, no. 1, pp. 264–274, 1992. View at Google Scholar
  50. A Inui, “Cancer anorexia-cachexia syndrome: are neuropeptides the key?,” Cancer Research, vol. 59, no. 18, pp. 4493–4501, 1999. View at Google Scholar
  51. D P Kotler, “Cachexia,” Annals of Internal Medicine, vol. 133, no. 8, pp. 622–634, 2000. View at Google Scholar · View at PubMed
  52. K Toda, N Kumagai, K Tsuchimoto et al., “Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis,” Journal of Gastroenterology, vol. 35, no. 3, pp. 214–220, 2000. View at Publisher · View at Google Scholar